We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Gets $487 Million Award of HHS Contract for Vaccine Plant
Novartis Gets $487 Million Award of HHS Contract for Vaccine Plant
February 2, 2009
Novartis won an eight-year, $487 million contract in which HHS will pay about 40 percent of the cost of building a manufacturing plant that can produce cell-based seasonal, pandemic and pre-pandemic influenza vaccines.